��ɫ��

��ɫ��

Donate To Research Join The AAN

Events

Resources For

Abstract Details

Title The Safety of Natalizumab in Patients with Relapsing Multiple Sclerosis: An Update from TOUCH and TYGRIS

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 095

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Carmen Bozic, MD (Biogen Idec)	No disclosure on file
	No disclosure on file
Marcello Moccia, MD, PhD	Marcello Moccia, 2019 has nothing to disclose.
	No disclosure on file
	No disclosure on file
Richard K. Kim, MD	Dr. Kim has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for RKK Consulting, Inc..
Frances Lynn, MSC	No disclosure on file
Michael A. Panzara, MD, MPH (Neurvati Neurosciences)	Dr. Panzara has received personal compensation for serving as an employee of Neurvati Neurosciences. Dr. Panzara has received personal compensation for serving as an employee of GRIN Therapeutics. Dr. Panzara has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Wave Life Sciences. Dr. Panzara has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Athira Pharma. Dr. Panzara has stock in GRIN Therapeutics. Dr. Panzara has stock in Cadenza Bio. Dr. Panzara has stock in Athira Pharma. Dr. Panzara has stock in Wave Life Sciences. Dr. Panzara has stock in Sanofi.